PT - JOURNAL ARTICLE AU - Lizanne JS Schweren AU - Jan Haavik AU - Lin Li AU - Berit Skretting Solberg AU - Henrik Larsson AU - Catharina A Hartman TI - Drinking habits and executive functioning: a propensity score-weighted analysis of 78,832 adults AID - 10.1101/2020.12.22.20248655 DP - 2020 Jan 01 TA - medRxiv PG - 2020.12.22.20248655 4099 - http://medrxiv.org/content/early/2020/12/22/2020.12.22.20248655.short 4100 - http://medrxiv.org/content/early/2020/12/22/2020.12.22.20248655.full AB - Excessive alcohol intake compromises cognitive functioning. At the same time, moderate alcohol consumption is reported to protect against Alzheimer’s disease among elderly. Little is known about dose-dependent effects of alcohol consumption on higher-order cognitive functioning among generally healthy adults. Here, we applied propensity weighted analyses to investigate associations between habitual drinking patterns and executive functioning in the general population.A community sample of N=78,832 Dutch adults (age 18-65, 40.9% male) completed the Ruff Figural Fluency Task of executive functioning (range 1-165), and self-reported their past month consumption of alcoholic beverages on a food frequency questionnaire. Participants were stratified according to drinking level (abstinent [22.0%], occasional [<2.5 g/day, 21.4%], light [2.5–14.9 g/day, 42.9%], moderate [15–29.9 g/day, 11.4%], or heavy [>30 g/day, 2.3%]) and binge-drinking (yes [10.6%] vs. no [89.4%]). Groups were equivalised using multinomial propensity score weighing based on demographic, socioeconomic, health-related and psychosocial factors influencing drinking behaviour.Compared to abstinent participants, task performance was better among light drinkers (β[95% CI]=0.056[0.033-0.078] or +1.3 points, p<0.0001) and moderate drinkers (β[95% CI]=0.111[0.079-0.143] or +2.5 points, p<0.0001), but not among occasional drinkers (β[95% CI]=0.018[-0.006-0.043], p=0.1432) or heavy drinkers (β[95% CI]=0.075[-0.009-0.158], p=0.0791). No difference was found between binge-drinkers and non-binge-drinkers (β[95% CI]=0.032[-0.002-0.066], p=0.0654).In conclusion, we observed better executive functioning in light-moderate drinkers compared to abstainers, but not in occasional drinkers, heavy drinkers or binge-drinkers. This non-linear association is reminiscent of the dose-dependent effect of alcohol consumption on cardiovascular risk. Further studies may determine whether cardiovascular, inflammatory and/or other somatic factors mediate the association between moderate drinking and higher-order cognitive functions. Although analyses were adjusted for observed factors that influence drinking behaviours, we cannot exclude a contribution from unobserved residual confounding.Competing Interest StatementDuring the past three years, JH has received educational speaking fees from HB Pharma, Biocodex, Medice, Takeda and Shire. H Larsson has served as a speaker for Evolan Pharma and Shire/Takeda and has received research grants from Shire/Takeda; all outside the submitted work. The other authors declare no competing interests. Funding StatementThis work was supported by the European Unions Horizon 2020 Research and Innovation Program under grant agreement No 728018. The funding source has had no involvement in the study design, data collection, interpretation of the findings, or writing of this manuscript.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Lifelines Cohort Study is conducted according to the principles of the Declaration of Helsinki and is approved by the medical ethics committee of the University Medical Center Groningen, The Netherlands.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data analyzed in this study was obtained from the Lifelines biobank (project application number OV15_0307). Requests to access this dataset should be directed to Lifelines Research Office (research{at}lifelines.nl). https://www.lifelines.nl/